Ajax-Loading

AstraZeneca PLC - Cash Ratio

AstraZeneca PLC's Fiscal Year is From January To December.

The item "Cash-Ratio" stands at 0.2403 as of 09/30/2025, the highest value since 09/30/2024.

As of the end of AstraZeneca PLC's third quarter, the item "Cash Ratio" stands at 0.2403. This represents an increase of 13.27 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 26.64 percent compared to the value the year prior.
The 1 year change in percent is 26.64.
The 3 year change in percent is 22.99.

The Serie's long term average value is 0.224. It's latest available value, on 09/30/2025, is 7.41 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is +34.75%.
The Serie's change in percent from it's maximum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is -12.87%.

Cash Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Cash Ratio905,699,262,464.00
LogoJohnson & Johnson - Cash Ratio486,508,953,600.00
LogoAbbVie Inc - Cash Ratio399,570,305,024.00
LogoRoche Holding AG - Cash Ratio317,433,206,677.55
LogoNovartis AG - Cash Ratio255,096,620,580.91